Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
CLDX
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -11.8%
CLDX
Celldex Therapeutics, Inc
Stonvex
☁️ News word cloud
Top words across the last 50 articles for this ticker.
celldex
therapeutics
phase
2024
barzolvolimab
urticaria
nasdaq
offering
price
study
results
analysts
chronic
data
announced
positive
after
analyst
common
their
StonvexStonvexStonvexStonvex